Loading clinical trials...
Loading clinical trials...
Phase II Single Arm Trial of FOLF(HA)Iri Plus Cetuximab in Irinotecan-naïve Second Line Patients With KRAS Wild Type Metastatic Colorectal Cancer
Conditions
Interventions
HA-Irinotecan
Locations
3
Australia
Liverpool Hospital
Sydney, New South Wales, Australia
Southern Medical Day Care Centre
Wollongong, New South Wales, Australia
Western General Hospital
Melbourne, Victoria, Australia
Start Date
June 1, 2014
Primary Completion Date
June 1, 2016
Completion Date
November 1, 2016
Last Updated
August 29, 2014
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Western General Hospital, Australia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions